DK0574571T3 - Farmaceutiske sammensætninger indeholdende polymerbundne anthracyclinglycosider og en fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutiske sammensætninger indeholdende polymerbundne anthracyclinglycosider og en fremgangsmåde til fremstilling deraf

Info

Publication number
DK0574571T3
DK0574571T3 DK93902124T DK93902124T DK0574571T3 DK 0574571 T3 DK0574571 T3 DK 0574571T3 DK 93902124 T DK93902124 T DK 93902124T DK 93902124 T DK93902124 T DK 93902124T DK 0574571 T3 DK0574571 T3 DK 0574571T3
Authority
DK
Denmark
Prior art keywords
bound
preparation
pharmaceutical compositions
compositions containing
containing polymer
Prior art date
Application number
DK93902124T
Other languages
Danish (da)
English (en)
Inventor
Marco Adami
Roberto Magrini
Paolo Maranghi
Antonino Suarato
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of DK0574571T3 publication Critical patent/DK0574571T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93902124T 1992-01-07 1992-12-21 Farmaceutiske sammensætninger indeholdende polymerbundne anthracyclinglycosider og en fremgangsmåde til fremstilling deraf DK0574571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200247A GB9200247D0 (en) 1992-01-07 1992-01-07 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
PCT/EP1992/002968 WO1993013804A1 (fr) 1992-01-07 1992-12-21 Compositions pharmaceutiques contenant des glycosides d'anthracycline lies a des derives polymeres, et leur procede de preparation

Publications (1)

Publication Number Publication Date
DK0574571T3 true DK0574571T3 (da) 1999-11-01

Family

ID=10708214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93902124T DK0574571T3 (da) 1992-01-07 1992-12-21 Farmaceutiske sammensætninger indeholdende polymerbundne anthracyclinglycosider og en fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (1) US6245358B1 (fr)
EP (1) EP0574571B1 (fr)
JP (1) JPH06505755A (fr)
KR (1) KR100290222B1 (fr)
AT (1) ATE179618T1 (fr)
AU (1) AU666513B2 (fr)
CA (1) CA2105466A1 (fr)
DE (1) DE69229109T2 (fr)
DK (1) DK0574571T3 (fr)
ES (1) ES2133380T3 (fr)
FI (1) FI933853A (fr)
GB (1) GB9200247D0 (fr)
GR (1) GR3030633T3 (fr)
HU (2) HU217806B (fr)
IL (1) IL104256A (fr)
MX (1) MX9207605A (fr)
NZ (1) NZ246577A (fr)
RU (1) RU2118171C1 (fr)
TW (1) TW218847B (fr)
UA (1) UA32522C2 (fr)
WO (1) WO1993013804A1 (fr)
ZA (1) ZA9210049B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
WO1998047496A2 (fr) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc. Composes a base de polymere et de platine
US5965118A (en) * 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds
US7314956B2 (en) 2001-08-08 2008-01-01 Vaxim, Inc. Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
WO2003017938A2 (fr) * 2001-08-22 2003-03-06 Watson Pharmaceuticals, Inc. Conjugue cibles sur des recepteurs cibles
US20030125268A1 (en) * 2002-08-28 2003-07-03 Rybak Mary Ellen Margaret Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
CN1703198A (zh) * 2002-10-25 2005-11-30 辉瑞产品公司 呈混悬剂形式的芳基杂环活性物质的贮库制剂
CN1774259B (zh) * 2003-01-14 2011-12-28 特瓦制药工业有限公司 治疗系统性红斑狼疮的肽的胃肠道外制剂
EP1814525A2 (fr) * 2005-05-11 2007-08-08 Sicor Inc. Glycosides d'anthracycline lyophylises stables
US20100160442A1 (en) * 2006-07-18 2010-06-24 Ossovskaya Valeria S Formulations for cancer treatment
ES2395690T3 (es) * 2007-01-16 2013-02-14 Bipar Sciences, Inc. Formulaciones para el tratamiento del cáncer
RU2488393C2 (ru) * 2007-11-12 2013-07-27 Новартис Аг Жидкие композиции, включающие валсартан
WO2009118754A2 (fr) * 2008-03-28 2009-10-01 Astron Research Limited Procédé pour préparer une composition lyophilisée stable
CA2723315A1 (fr) * 2008-04-30 2009-11-05 Ben-Gurion University Of The Negev Research And Development Authority Systemes d'administration vasculaire
KR102239752B1 (ko) * 2019-12-11 2021-04-13 한국과학기술연구원 종양 특이적 약물복합체와 항pd-l1 항체를 유효성분으로 하는 암 예방 또는 치료를 위한 병용 투여용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (fr) * 1974-04-23 1977-03-31
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
FR2583983B1 (fr) * 1985-06-07 1988-05-27 Centre Nat Rech Scient Nouvelles prodrogues macromoleculaires hydrosolubles, leur preparation et leur utilisation comme medicaments notamment antitumoraux et antiparasitaires
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US4968742A (en) * 1987-11-09 1990-11-06 Miles Inc. Preparation of ligand-polymer conjugate having a controlled number of introduced ligands
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

Also Published As

Publication number Publication date
EP0574571A1 (fr) 1993-12-22
DE69229109D1 (de) 1999-06-10
UA32522C2 (uk) 2001-02-15
IL104256A (en) 1997-02-18
HUT74578A (en) 1997-01-28
ATE179618T1 (de) 1999-05-15
TW218847B (fr) 1994-01-11
MX9207605A (es) 1993-08-01
EP0574571B1 (fr) 1999-05-06
GB9200247D0 (en) 1992-02-26
HU9302517D0 (en) 1993-12-28
HU211636A9 (en) 1995-12-28
JPH06505755A (ja) 1994-06-30
WO1993013804A1 (fr) 1993-07-22
FI933853A0 (fi) 1993-09-03
ZA9210049B (en) 1993-10-06
FI933853A (fi) 1993-09-03
CA2105466A1 (fr) 1993-07-08
ES2133380T3 (es) 1999-09-16
NZ246577A (en) 1996-03-26
US6245358B1 (en) 2001-06-12
AU3346893A (en) 1993-08-03
AU666513B2 (en) 1996-02-15
IL104256A0 (en) 1993-05-13
GR3030633T3 (en) 1999-10-29
HU217806B (hu) 2000-04-28
DE69229109T2 (de) 1999-08-26
KR100290222B1 (ko) 2001-09-17
RU2118171C1 (ru) 1998-08-27

Similar Documents

Publication Publication Date Title
DK0574571T3 (da) Farmaceutiske sammensætninger indeholdende polymerbundne anthracyclinglycosider og en fremgangsmåde til fremstilling deraf
MX9203072A (es) Asialoglucoproteina-agente conjugado medicinal.
US4664911A (en) Immunotoxin conjugates employing toxin B chain moieties
IE852593L (en) Compositions containing anthracycline glycosides
EP0328147A2 (fr) Immunoconjugués d'anthracyclines à spacer et leurs procédés de préparation
IL47372A (en) Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
NO971622D0 (no) Saponinpreparater og anvendelse derav i immunstimulerende komplekser
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
HU9400800D0 (en) Polymer-bound paclitaxel derivatives process for producing them and pharmaceutical compositions containing them
RU93055778A (ru) Фармацевтические композиции, содержащие антрациклиновые гликозиды, связанные с полимерным производным, и способ их получения
MY103365A (en) 4-demethoxy-4-amino-anthracyclines
FI902387A0 (fi) Antracyklinkonjugat med en ny linker och foerfaranden foer deras framstaellning.
WO1994010317A3 (fr) Vaccin conjugue contre des streptocoques du groupe b
AU632036B2 (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
MY110974A (en) Anthracycline conjugates, their preparation and their use as antitumor agents
CA2504963A1 (fr) Conjugues de tnf et un ligand du recepteur cd13 utilises en combinaison avec des interferons gamma pour le traitement du cancer
AU545885B2 (en) Oral absorption of glycosidic antibiotics
NZ220604A (en) Anthracycline glycoside derivatives, their preparation and pharmaceutical compositions containing them
Miescher-Granger et al. Biological activities of human recombinant interferon α/β targeted by anti‐Epstein‐Barr virus monoclonal antibodies
SE8300324L (sv) Daunorubicin och doxorubicin-analoger, deras framstellning och anvendning
GB1291414A (en) Aerosol composition
GB1193790A (en) 04beta-Hydroxy-Delta<4,20,22>-Bufatrienolide-3-Ethers and process for their preparation